You have no items in your shopping cart.
News
AVS Bio completes acquisition of Biorbyt →
The primary source of discovery, now at global scale.
We are bridging the gap between biological discovery and the laboratory bench, bringing premium biologics directly to researchers.
The Unified Ecosystem
Connecting the source to the scientist.
For over 60 years, AVS Bio has operated as the foundational engine behind breakthroughs in vaccines and diagnostics. Today, by integrating our proprietary manufacturing directly with Biorbyt's global digital infrastructure, we are creating a frictionless pipeline from our laboratories directly to yours.
The Power of Integration
Bringing together foundational manufacturing and expansive digital reach.
The Manufacturing Engine
- Primary Scale: Over 60 years of foundational biologics production, including 1B+ SPF eggs produced.
- Discovery Platforms: World-class custom IgY antibody production powered by the proprietary rPEx platform.
- Rigorous Compliance: USDA-licensed For Further Manufacture products and validated 9 CFR testing.
The Digital Footprint
- Seamless Distribution: Established global delivery infrastructure spanning key hubs across Europe, North America, and Asia.
- Unrivaled Catalog: A deeply curated, highly accessible e-commerce catalog featuring 1.5M+ reagents.
- Scientific Partnership: Peer-to-peer technical guidance developed entirely by scientists, for scientists.
Explore Combined Capabilities
Our combined infrastructure powers an end-to-end suite of custom biological services.
Custom Antibody Discovery & Development
From early tool generation through preclinical testing, leverage our integrated platform to accelerate your biologics pipeline.
View Full Overview
Tool Generation
Custom antigens, recombinant proteins, and target-expressing cell lines designed for biological relevance.
Immunization
Tailored immunization strategies across species to elicit robust and diverse immune responses.
Antibody Discovery
Accelerate hit identification using robust B cell selection, phage display, and specialized platforms.
Antibody Characterization
Comprehensive in vitro assays to define binding kinetics, epitope bins, and functional activity.
Developability Profiling
Early risk assessment and liability identification to ensure downstream manufacturability.
Optimization & Engineering
Targeted affinity maturation, humanization, and sequence de-risking for lead candidates.
Cell Line Development
Generation of stable, high-yield cell lines (HEK293/CHO) and Master Cell Bank (MCB) establishment.
Protein Production
Seamless transition to recombinant protein production at scales up to 150 liters.
Preclinical Testing Services
Rigorous in vivo and in vitro testing to evaluate safety, efficacy, and pharmacokinetics.
An End-to-End Biological Ecosystem
Trace the journey of premium biologics from primary discovery directly to your laboratory bench.
AVS Bio
1. Primary Discovery
Large-scale production and proprietary rPEx platform discovery.
Combined
2. Rigorous Validation
USDA-licensed 9 CFR testing ensuring unmatched lot-to-lot quality.
Biorbyt
3. Global Catalog
Direct integration into a 1.5M+ global digital e-commerce network.
Researcher
4. Your Laboratory
Fast, direct delivery of premium reagents to your workbench.
Biorbyt – with its expansive portfolio of antibodies, proteins, and reagents, and advanced ecommerce platform – marks an important step in our journey to becoming a truly diversified, leading and global biomaterials provider and will allow us to reach more customers in more geographies than ever before. We’re thrilled to welcome the Biorbyt team to the AVS Bio platform.
We are very excited to join the growing AVS Bio family. Our combined catalog, along with our ecommerce platform and data-driven commercial tools, creates a powerful engine to serve researchers around the world and bring an even broader portfolio of high-quality biomaterials to our joint global customer base.
Accelerate Your Science
Leverage the combined power of primary biologics manufacturing and a world-class digital catalog to advance your next breakthrough.